Home/Frantz Viral Therapeutics/Mihaela Plesa, BA, CCRP

MP

Mihaela Plesa, BA, CCRP

Director, Clinical Research Programs

Frantz Viral Therapeutics

Therapeutic Areas

Infectious Disease Oncology

Frantz Viral Therapeutics Pipeline

Drug	Indication	Phase
Artesunate Vaginal Insert	Cervical High-Grade Squamous Intraepithelial Lesion (HSIL)	Phase 2B
Artesunate Ointment	Vulvar High-Grade Squamous Intraepithelial Lesion (HSIL)	Phase 2B
Artesunate Anal Suppository	Anal High-Grade Squamous Intraepithelial Lesion (HSIL) in HIV-negative patients	Phase 2B

Leadership Team at Frantz Viral Therapeutics

Chairman and CEO

C. Richard Schlegel, MD, PhD

Scientific Advisor / Inventor

Cornelia L. Trimble, MD

Scientific Advisor / Global PI for Cervical & Vulvar Trials

View full Frantz Viral Therapeutics profile